Loading chat...
NY A03573
Bill
Status
Introduced
1/25/2011
Primary Sponsor
Peter Rivera
Click for details
AI Summary
- Amends Public Health Law Section 272 to add asthma medications to the list of drugs exempt from prior authorization requirements under the preferred drug program
- Exempts all medications indicated by the FDA for asthma treatment from prior authorization, joining existing exemptions for atypical anti-psychotics, anti-depressants, anti-retrovirals for HIV/AIDS, and anti-rejection drugs for transplants
- Modifies Public Health Law Section 274 to clarify criteria for determining prior authorization requirements, including consideration of drug overuse, abuse, and availability of alternative treatments
- Takes effect immediately upon enactment
Legislative Description
Provides that there shall be no prior authorization required under the preferred drug program for all medications indicated by the federal Food and Drug Administration for the treatment of asthma.
Last Action
enacting clause stricken
9/4/2012
Committee Referrals
Health1/25/2011
Full Bill Text
No bill text available